Drugs / SL-701
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02078648 | May 2014 → Sep 2017 | adult glioblastoma | Stemline Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SL-701 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02078648 ↗ |
| Modality | Vaccine | “Glioma-Associated Antigen Vaccine” NCT02078648 ↗ |
| Route | Subcutaneous | “Preferred site of SC injection is in the right or left upper arms” NCT02078648 ↗ |